REG - One Health Group PLC - Director/PDMR Shareholding
31/03/2023 09:30
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230331:nRSe9187Ua&default-theme=true
RNS Number : 9187U One Health Group PLC 31 March 2023
One Health Group PLC
PDMR Share Dealing
TR1 - Notification of Major Holdings
31 March 2023
One Health Group PLC ("One Health" or the "Company") announces that Shantanu
Shahane, a director and person discharging managerial responsibilities in the
Company, purchased 60,000 ordinary shares of 0.5 pence each in the capital
of the Company ("Ordinary Shares") following the exercise of options granted
under the One Health Group Share Option Plan ("Share Options").
Further details of the disclosure made to the Company by Shantanu Shahane are
contained in Appendix 1.
Following the above dealing, Shantanu Shahane is, directly or indirectly,
beneficially interested in 350,000 Ordinary Shares representing 3.33% of the
issued share capital of the Company.
Appendix 2 contains a disclosure form relating to Shantanu Shahane who has
notified One Health that he controls over 3% of the Total Voting Rights in the
Company as a result of his acquisition of Ordinary Shares outlined above.
Following the exercise of the Share Options, Derek Bickerstaff, a director and
Chair of One Health and who controls over 3% of the Total Voting Rights in the
Company, has notified One Health that his percentage interest in Ordinary
Shares has reduced to approximately 57.09% of the issued share capital of the
Company. Derek Bickerstaff did not acquire Ordinary Shares as a result of
the exercise of the Share Options. Further details are contained in the
disclosure form in Appendix 3.
This announcement contains inside information for the purposes of Article 7 of
EU Regulation
596/2014. Which is part of the United Kingdom domestic law pursuant to the
Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)("UK MAR").
The directors of One Health accept responsibility for this announcement.
Enquiries
One Health Group plc Via Square 1 Consulting
Oberon Capital (AQSE Corporate Adviser and Broker) 020 3179 5300
Nick Lovering, Mike Seabrook
Square 1 Consulting 020 7929 5599
David Bick
Appendix 1
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.
1. Details of the person discharging managerial responsibilities/person closely
associated
a) Name: Shantanu Shahane
2. Reason for the notification
a) Position/status: Medical Director
b Initial notification/Amendment: Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name: One Health Group plc
b) LEI: 984500DC689F5BAD8732
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument: Ordinary shares of
£0.005 each
Identification code:
ISIN Code: GB00BNNT0595
b) Nature of the transaction: Purchase of share pursuant to the exercise of options
c) Price(s) and Volume (s): Purchase price(s). 66.7p per share
Volume(s): 60,000
d) Aggregated Information: 60,000
Aggregated volume:
Price: £40,200
e) Date of the transaction: 30 March 2023
f) Place of the transaction Aquis (AQSE)
Appendix 2
Disclosure forms re major share holdings
TR-1: standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the
FCA in Microsoft Word format if possible) (i)
1a. Identity of the issuer or the underlying issuer of existing shares to ONE HEALTH GROUP PLC
which voting rights are attached (ii):
131 Psalter Lane Sheffield S11 8UX
LEI: 984500DC689F5BAD8732
1b. Please indicate if the issuer is a non-UK issuer (please mark with an
"X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with
an "X")
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) (iii):
3. Details of person subject to the notification obligation (iv)
Name Shantanu Shahane
City and country of registered office (if applicable)
4. Full name of shareholder(s) (if different from 3.) (v)
Name As above
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached (vi): 30(th) March 2023
6. Date on which issuer notified (DD/MM/YYYY): 30(th) March 2023
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A) % of voting rights through financial instruments Total of both in % (8.A + 8.B) Total number of voting rights held in issuer (8.A + 8.B) (vii)
(total of 8.B 1 + 8.B 2)
Resulting situation on the date on which threshold was crossed or reached 3.33% 3.33% 350,000
Position of previous notification (if N/A N/A
applicable)
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights (ix) % of voting rights
shares
ISIN code (if possible)
Direct Indirect Direct Indirect
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
GB00BNNT0595 60,000 290,000 0.57% 2.76%
SUBTOTAL 8. A 350,000 3.33%
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument Expiration Exercise/ Number of voting rights that may be acquired if the instrument is % of voting rights
date (x)
Conversion Period (xi)
exercised/converted.
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R
(1) (b)
Type of financial instrument Expiration Exercise/ Physical or cash Number of voting rights % of voting rights
date (x)
Conversion Period (xi)
Settlement (xii)
SUBTOTAL 8.B.2
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural
person or legal entity and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying) issuer (xiii)
Full chain of controlled undertakings through which the voting rights and/or x
the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity (please add additional rows as
necessary) (xiv)
Name (xv) % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher Total of both if it equals or is higher than the notifiable threshold
than the notifiable threshold
Shantanu Shahane 0.57% 0.57%
Shahane Consultancy Ltd 2.76% 2.76%
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information (xvi)
Place of completion Aquis (AQSE)
Date of completion 30(th) March 2023
Appendix 3
TR-1: standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the
FCA in Microsoft Word format if possible)
1a. Identity of the issuer or the underlying issuer of existing shares to ONE HEALTH GROUP PLC
which voting rights are attached (ii):
131 Psalter Lane Sheffield S11 8UX
LEI: 984500DC689F5BAD8732
1b. Please indicate if the issuer is a non-UK issuer (please mark with an
"X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with
an "X")
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights X
Other (please specify) (iii):
3. Details of person subject to the notification obligation (iv)
Name Derek Richard Bickerstaff
City and country of registered office (if applicable)
4. Full name of shareholder(s) (if different from 3.) (v)
Name As above
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached (vi): 30(th) March 2023
6. Date on which issuer notified (DD/MM/YYYY): 30(th) March 2023
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A) % of voting rights through financial instruments Total of both in % (8.A + 8.B) Total number of voting rights held in issuer (8.A + 8.B) (vii)
(total of 8.B 1 + 8.B 2)
Resulting situation on the date on which threshold was crossed or reached 57.09% 57.09% 6,000,000
Position of previous notification (if 59.8% 59.8%
applicable)
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights (ix) % of voting rights
shares
ISIN code (if possible)
Direct Indirect Direct Indirect
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
GB00BNNT0595 6,000,000 57.09%
SUBTOTAL 8. A 6,000,000 57.09%
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
Type of financial instrument Expiration Exercise/ Number of voting rights that may be acquired if the instrument is % of voting rights
date (x)
Conversion Period (xi)
exercised/converted.
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R
(1) (b)
Type of financial instrument Expiration Exercise/ Physical or cash Number of voting rights % of voting rights
date (x)
Conversion Period (xi)
Settlement (xii)
SUBTOTAL 8.B.2
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural x
person or legal entity and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying) issuer (xiii)
Full chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity (please add additional rows as
necessary) (xiv)
Name (xv) % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher Total of both if it equals or is higher than the notifiable threshold
than the notifiable threshold
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information (xvi)
Place of completion Aquis (AQSE)
Date of completion 30(th) March 2023
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHGRGDXBBXDGXBRecent news on Lloyds Banking
See all newsREG - Lloyds Banking Group - Transaction in Own Shares
AnnouncementREG - Lloyds Banking Group - Total Voting Rights
AnnouncementREG - Lloyds Banking Group - Transaction in Own Shares
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 28/08/2025
Announcement